Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Russell 2000 Growth ETF (NQ:VTWG)

241.41 +2.24 (+0.94%)
Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,639
Open 240.25
Bid (Size) 227.26 (1)
Ask (Size) 254.72 (1)
Prev. Close 239.17
Today's Range 238.80 - 241.94
52wk Range 160.03 - 246.00
Shares Outstanding N/A
Dividend Yield 0.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Wealth Firm Just Sold $8 Million in Small-Cap Stocks — Here’s Why
This Wealth Firm Just Sold $8 Million in Small-Cap Stocks — Here’s Why 
Via The Motley Fool
Topics ETFs Regulatory Compliance
BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial
BridgeBio now intends to file a new drug application for the therapy's approval in the first half of 2026. 
Via Stocktwits

Performance

YTD
+14.4%
+14.4%
1 Month
+3.2%
+3.2%
3 Month
+16.1%
+16.1%
6 Month
+26.3%
+26.3%
1 Year
+18.1%
+18.1%

More News

Read More
DNUT Stock Trades Above 200-DMA For The First Time Since November 2024
Via Stocktwits
Topics ETFs
Beyond Meat Stock Skyrockets 60% Today: Meme Stock Frenzy Intensifies After ETF Inclusion Amid Surging Retail Buzz
Via Stocktwits
Topics Artificial Intelligence ETFs
Candel Therapeutics Enters $130M Term Loan Facility To Advance Lead Product Candidate In Treatment Of Lung Cancer
Via Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals
Via Stocktwits
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside
Via Stocktwits
Capricor Stock Rises Pre-Market Over Fresh Hopes of Deramiocel Approval In Treating Genetic Disorder
Via Stocktwits
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment
Via Stocktwits
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Via Stocktwits
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year
Via Stocktwits
Krispy Kreme Stock Pops After FBI Director Kash Patel Reportedly Endorses It As A ‘Good Investment’: Retail Chatter Soars Over 600%
Via Stocktwits
Why Is aTyr Stock Falling Today?
Via Stocktwits
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’
Via Stocktwits
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda
Via Stocktwits
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
Via Stocktwits
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate
Via Stocktwits
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants
Via Stocktwits
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
Via Stocktwits
US FDA Withdraws Approval For Amylyx’s Neurodegenerative Disorder Drug, But BofA Hikes Price Target
Via Stocktwits
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail
Via Stocktwits
X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target
Via Stocktwits
Topics Economy
CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock
Via Stocktwits
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why
Via Stocktwits
Topics Death
Capricor Stock Plunges Pre-Market After US FDA Declines Approval For Muscular Disorder Therapy
Via Stocktwits

Frequently Asked Questions

Is Vanguard Russell 2000 Growth ETF publicly traded?
Yes, Vanguard Russell 2000 Growth ETF is publicly traded.
What exchange does Vanguard Russell 2000 Growth ETF trade on?
Vanguard Russell 2000 Growth ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Vanguard Russell 2000 Growth ETF?
The ticker symbol for Vanguard Russell 2000 Growth ETF is VTWG on the Nasdaq Stock Market
What is the current price of Vanguard Russell 2000 Growth ETF?
The current price of Vanguard Russell 2000 Growth ETF is 241.41
When was Vanguard Russell 2000 Growth ETF last traded?
The last trade of Vanguard Russell 2000 Growth ETF was at 10/31/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.